Advertisement

Reactions Weekly

, Volume 1673, Issue 1, pp 295–295 | Cite as

Pembrolizumab

Immune-mediated diabetes: case report
Case report
  • 27 Downloads

Reference

  1. Verlekar P, et al. Immune-mediated diabetes due to pembrolizumab. Practical Diabetes 34: 250-251, No. 7, Sep 2017. Available from: URL: http://doi.org/10.1002/pdi.2129 - United KingdomCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations